IMN || FDA & CDC

Apremilast approval expanded to include plaque psoriasis

Posted on: 24/09/2014 - 20:48

The oral phosphodiesterase-4 inhibitor apremilast is now indicated for the treatment of moderate to severe plaque psoriasis. On Sept. 23, the manufacturer, Celgene, announced that the Food and Drug...

Field of Interest: Dermatology

Type: News Item

ACIP recommends PCV13 for all adults 65 and up

Posted on: 23/09/2014 - 21:52

All adults who are 65 years or older should receive 13-valent pneumococcal conjugate vaccine (PCV13) routinely in series with 23-valent pneumococcal polysaccharide vaccine (PPSV23), according to a...

Field of Interest: Geriatrics

Type: News Item

Births to unmarried women down since 2008

Posted on: 21/08/2014 - 21:35

The nonmarital birth rate for women aged 15-44 years has declined 14% since peaking in 2007 and 2008, the National Center for Health Statistics reported. The rate was 44.8 births per 1,000 unmarried...

Field of Interest: Pulmonology

Type: News Item

FDA okays DNA stool test for CRC screening; Medicare considers coverage

Posted on: 12/08/2014 - 21:00

The Food and Drug Administration has approved another noninvasive alternative to colonoscopy for screening for colorectal cancer, this one a stool-based test that detects the presence of red blood...

Field of Interest: Gastroentero...

Type: News Item

FDA approves oritavancin for skin infections

Posted on: 07/08/2014 - 18:35

The Food and Drug Administration has approved the injectable antibiotic oritavancin (Orbactiv) to treat adults with acute bacterial skin and skin structure infections that might be caused by...

Field of Interest: Dermatology

Type: News Item

FDA advises against Enhancement intranasal splint as dermal filler

Posted on: 06/08/2014 - 18:00

The Food and Drug Administration has issued a warning about adverse events associated with use of the Expression intranasal splint as a dermal filler

Field of Interest: Dermatology

Type: News Item

High gonorrhea reinfection rate underscores need for rescreening

Posted on: 27/06/2014 - 18:10

ATLANTA – Gonorrhea reinfection rates are high among women in Florida, with more than 1 in 4 becoming reinfected after treatment, according to a review of surveillance data. Of 9,923 female Florida...

Field of Interest: Pulmonology

Type: News Item

OTC topical acne meds can cause severe reactions

Posted on: 25/06/2014 - 20:55

The Food and Drug Administration says that some over-the-counter acne products can cause severe hypersensitivity or allergic reactions and is warning consumers to discontinue use immediately and seek...

Field of Interest: Dermatology

Type: News Item

FDA approves tedizolid for acute bacterial skin infections

Posted on: 21/06/2014 - 00:10

Tedizolid, an oxazolidinone antibacterial drug, has been approved as an intravenous and oral treatment for acute bacterial skin and skin structure infections caused by gram positive bacteria, the...

Field of Interest: Dermatology

Type: News Item

FDA reclassifies tanning beds; warns against use by teens

Posted on: 29/05/2014 - 20:45

The Food and Drug Administration is requiring all tanning beds to carry a "black box" warning that the devices should not be used by children under age 18 years. The labeling doesn’t...

Field of Interest: Dermatology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters